Latest National Institute of Neurological Disorders and Stroke Stories
NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass, are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile X syndrome, the most common inherited cause of intellectual disability.
NEW YORK, Oct. 22 /PRNewswire/ -- NexGenix Pharmaceuticals Holdings, Inc.
Parkinson disease progresses more slowly in patients who have higher levels of urate, a chemical that at very high level is associated with gout, scientists have found.
Individuals with Parkinson's disease who have higher levels of a metabolite called urate in their blood and in cerebrospinal fluid (CSF) have a slower rate of disease progression, according to a study funded by the National Institutes of Health.
EAST SETAUKET, N.Y., July 2 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings (OTC Bulletin Board: LIXT) announced today that investigators of the National Institute of Neurological Disorders and Stroke (NINDS) and the National Cancer Institute (NCI), National Institutes of Health and Lixte reported that its novel compound, LB-1.2, enhances the effectiveness of two standard chemotherapy drugs in mouse models of human cancers.
People who received a mild electrical current to a motor control area of the brain were significantly better able to learn and perform a complex motor task than those in control groups.
Deep brain stimulation to help reduce tremors and other symptoms in people with Parkinson's disease has some serious side effects, a U.S. study finds. These include infection at the surgical site and cognitive decline, the study of 225 advanced Parkinson's patients at seven U.S.
Bolder BioTechnology has obtained a $1.6 million Phase II continuing renewal small business innovation research grant from the National Institute of Neurological Disorders and Stroke of The National Institutes of Health.
NeoPharm, a biopharmaceutical company, has signed a cooperative R&D agreement with the National Institute of Neurological Diseases and Stroke, a part of the National Institutes of Health for research on a therapeutic agent for untreatable brain diseases in humans.
- An armed gangster.